← Leaderboards
Antonio Morales-Hernandez
St. Jude Children'S Research Hospital
$918,541
Attributed
$918,541
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2020–25$250K$187.5K$125K$62.5K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$918,541 · 2
By mechanism
R00$737,041 · 1
K99$181,500 · 1
Top collaborators
No co-investigators on record.
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Robert J Ogg$4,822,843
- Mary K Danks$3,590,066
- Clinton F Stewart$6,135,444
- Charles G. Mullighan$25,123,215
- Erich William Damm$679,500
Others in their field
Other Emerging Leaders on “Gene Therapy”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,358,801
- George Mitra · Leidos Biomedical Research, Inc.$23,876,869
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
Research focus
Gene TherapyAffectB Cell DifferentiationGene ExpressionBehaviorBone Marrow TransplantationCell CompartmentationBindingCell CycleFamily MemberB-LymphocytesCellsCell StromaCurative TreatmentsCxcr4 GeneDifferential ExpressionCell CountEngraftmentEnsureEnvironmentCell LineageBloodFamilyGenetic
Grant awards (5)
GPRASP family as novel regulators in hematopoietic stem cells$249,001
R00 · FY2025 · DK · contact PI
GPRASP family as novel regulators in hematopoietic stem cells$239,040
R00 · FY2024 · DK · contact PI
GPRASP family as novel regulators in hematopoietic stem cells$249,000
R00 · FY2023 · DK · contact PI
GPRASP family as novel regulators in hematopoietic stem cells$90,000
K99 · FY2021 · DK · contact PI
GPRASP family as novel regulators in hematopoietic stem cells$91,500
K99 · FY2020 · DK · contact PI